Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pantothenate Kinase-associated Neurodegeneration (PKAN)”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableStudy completedNCT04182763
What this trial is testing

CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)

Who this might be right for
Pantothenate Kinase-Associated Neurodegeneration
Oregon Health and Science University 77
Not applicableUnknownNCT05696912
What this trial is testing

Functional Tests to Resolve Unsolved Rare Diseases. Rares.

Who this might be right for
Intellectual DisabilityRubinstein-Taybi SyndromeCystic Fibrosis+4 more
University Hospital, Bordeaux 50
Not applicableLooking for participantsNCT06596746
What this trial is testing

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Who this might be right for
Neurodegenerative DiseasesParkinson DiseaseSynucleinopathies+15 more
Casa di Cura San Raffaele Cassino 600
Large-scale testing (Phase 3)Ended earlyNCT03041116
What this trial is testing

Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants

Who this might be right for
Pantothenate Kinase-Associated Neurodegeneration
Travere Therapeutics, Inc. 84
Not applicableStudy completedNCT05615571
What this trial is testing

Testing of NBIA Genes: Analysis of Genetic Heterogeneity and Validation of Mitochondrial Markers for Assessing Causality of Sequence Variants.

Who this might be right for
Neurodegeneration With Brain Iron Accumulation (NBIA)
University Hospital, Bordeaux 70
Not applicableNo Longer AvailableNCT02635841
What this trial is testing

Compassionate Use of Deferiprone in Patients With PKAN

Who this might be right for
Pantothenate Kinase-Associated Neurodegeneration
Chiesi Canada Corp
Large-scale testing (Phase 3)Study completedNCT01741532
What this trial is testing

Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)

Who this might be right for
Pantothenate Kinase-Associated Neurodegeneration
ApoPharma 89
Not applicableUnknownNCT04319796
What this trial is testing

European Registry on Rare Neurological Diseases

Who this might be right for
Rare Diseases
University Hospital Tuebingen 5,000
Not applicableLooking for participantsNCT05522374
What this trial is testing

TIRCON International NBIA Registry

Who this might be right for
Neurodegeneration With Brain Iron Accumulation (NBIA)Pantothenate Kinase-associated Neurodegeneration (PKAN)Beta-Propeller Protein-Associated Neurodegeneration (BPAN)+8 more
LMU Klinikum 2,000
Large-scale testing (Phase 3)Study completedNCT02174848
What this trial is testing

Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration

Who this might be right for
Pantothenate Kinase-Associated Neurodegeneration
ApoPharma 68
Not applicableStudy completedNCT01838018
What this trial is testing

Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)

Who this might be right for
Pantothenate Kinase-associated Neurodegeneration (PKAN)
Susan J. Hayflick 10
Not applicableUnknownNCT02587858
What this trial is testing

NBIAready: Online Collection of Natural History Patient-reported Outcome Measures

Who this might be right for
Neurodegeneration With Brain Iron Accumulation (NBIA)
Susan J. Hayflick 300